Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02649855 | Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer | completed | Phase 2 | 74 | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2026 | clinicaltrials |
| NCT03218826 | PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 | 23 | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2026 |
| NCT04558398 | Impact of Exercise on Mitochondria in Cancer Patients.(ICCE-Mito) | completed | N/A | 15 | University of NottinghamOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT05133440 | A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones | completed | Phase 2 | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT06104449 | A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005) | completed | Phase 1 | 7 | Merck Sharp & Dohme LLCINDUSTRY | 1 | Apr 27, 2026 | clinicaltrials |
| NCT04305925 | Focal Laser Ablation of Prostate Cancer | completed | Early Phase 1 | 10 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT02104362 | Single Fraction Early Prostate Irradiation (SiFEPI)(SiFEPI) | completed | N/A | 35 | Centre Antoine LacassagneOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT04925648 | Psma Intensity Can be Altered by Androgen and Phospho-SrC Obstruction(PICASSO) | completed | Phase 2 | 4 | St Vincent's Hospital, SydneyOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT04523207 | A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases | completed | Phase 2 | 108 | Janssen Research & Development, LLCINDUSTRY | 1 | Apr 21, 2026 | clinicaltrials |
| NCT05022849 | A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants | completed | Phase 1 | 15 | Janssen Research & Development, LLCINDUSTRY | 1 | Apr 17, 2026 | clinicaltrials |
| NCT06610474 | Evaluation of an Online Prostate Cancer Screening Decision Aid | completed | N/A | 88 | David SiegelFED | 1 | Apr 17, 2026 | clinicaltrials |
| NCT07533344 | Ga-68 PSMA PET/CT vs mpMRI in Cognitive Prostate Biopsy(PSMA-MRI BX) | completed | — | 60 | Fatih Sultan Mehmet Training and Research HospitalOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT03935282 | Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors(AH-HA) | completed | N/A | 645 | Wake Forest University Health SciencesOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT01902680 | Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant.(CURIEFOCALE) | completed | Phase 2 | 18 | Institut Claudius RegaudOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT01982786 | Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer | completed | N/A | 57 | Canadian Cancer Trials GroupNETWORK | 1 | Apr 13, 2026 | clinicaltrials |
| NCT02225704 | Radium-223 in Combination With Enzalutamide | completed | Phase 2 | 45 | Cancer Trials IrelandNETWORK | 1 | Apr 13, 2026 | clinicaltrials |
| NCT02772588 | AASUR in High Risk Prostate Cancer | completed | Phase 2 | 64 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT05461430 | Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)(TraveraRTGx) | completed | — | 72 | Travera IncINDUSTRY | 1 | Apr 13, 2026 | clinicaltrials |
| NCT02433197 | Effectiveness of an Individualized Program of Muscular Strength and Endurance Program for Improving Germ Cell Cancer(EFICATEST) | completed | N/A | 20 | University of MalagaOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT04081779 | Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study | completed | N/A | 261 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT04533958 | Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy(HypProMet) | completed | N/A | 53 | Saint-Gregoire Private Hospital CenterOTHER | 2 | Apr 6, 2026 | clinicaltrials |
| NCT04582656 | Efficacy Assessment of a Novel 3D Cartography-based Targeted Focal Microwave Therapy in Men With Localized Intermediate-risk Prostate Cancer(VIOLETTE) | completed | N/A | 76 | KoelisINDUSTRY | 2 | Apr 6, 2026 | clinicaltrials |
| NCT03660085 | Prostate Cancer - Patient Empowerment Program(PC-PEP) | completed | N/A | 140 | Nova Scotia Health AuthorityOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT07510685 | Closed-System Bladder Irrigation to Reduce Urinary Tract Infections After Endoscopic Urologic Surgery (IRIS Trial)(IRIS) | completed | N/A | 240 | University of PisaOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT02044354 | Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate Cancer(CABA-DOC) | completed | Phase 3 | 195 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT05553327 | Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy. | completed | N/A | 100 | Hospital Clinic of BarcelonaOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT03496805 | Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy | completed | Phase 2 | 106 | Wake Forest University Health SciencesOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT03674814 | Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer | completed | Phase 1 | 42 | University of ChicagoOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT05231915 | Prevalence of the c.853delT Mutation of the HOXB13 Gene in Prostate Cancer in Martinique(HOXB13_Mart) | completed | N/A | 465 | University Hospital Center of MartiniqueOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT04705038 | Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments | completed | N/A | 101 | University of ChicagoOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT06435546 | Adherence to Oral Therapies in Advanced Breast and Prostate Cancers(AdOTAC) | completed | N/A | 200 | Institut de Cancérologie de LorraineOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07074405 | Acceptability of Artificial Intelligence in the Diagnosis of Prostate Cancer(AccAI) | completed | N/A | 51 | Centre Hospitalier Universitaire de LiegeOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT06136598 | A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001) | completed | Phase 1 | 14 | Merck Sharp & Dohme LLCINDUSTRY | 1 | Mar 19, 2026 | clinicaltrials |
| NCT07477756 | A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients | completed | — | 1,247 | Novartis PharmaceuticalsINDUSTRY | 1 | Mar 19, 2026 | clinicaltrials |
| NCT07428642 | PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC. | completed | — | 168 | First Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT01804712 | Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy | completed | Early Phase 1 | 8 | Christopher KaneOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT02213913 | Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas | completed | Phase 1 / Phase 2 | 55 | University of ChicagoOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT07464964 | Effects of Music Therapy on Anxiety and Distress Levels During Radionuclide Treatment in Prostate Cancer Patients(MUSIC-PRT) | completed | N/A | 60 | Dokuz Eylul UniversityOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT05012813 | Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer | completed | N/A | 28 | OHSU Knight Cancer InstituteOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT00160979 | Transrectal Tumour Oxygen - US Army | completed | Phase 2 | 186 | University Health Network, TorontoOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT00936390 | Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer | completed | Phase 3 | 1,538 | Radiation Therapy Oncology GroupNETWORK | 2 | Mar 6, 2026 | clinicaltrials |
| NCT01546987 | Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer | completed | Phase 3 | 239 | Radiation Therapy Oncology GroupNETWORK | 2 | Mar 6, 2026 | clinicaltrials |
| NCT01567800 | Prostate Hypoxia FAZA | completed | N/A | 18 | University Health Network, TorontoOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT05764005 | Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study | completed | N/A | 39 | University of Michigan Rogel Cancer CenterOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT06184867 | Choices About Genetic Testing And Learning Your Risk With Smart Technology(CATALYST) | completed | N/A | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT00063882 | Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer | completed | Phase 3 | 588 | Radiation Therapy Oncology GroupNETWORK | 2 | Mar 5, 2026 | clinicaltrials |
| NCT05008900 | Timing of Post-prostatectomy PSMA Imaging(TOPP) | completed | Phase 2 | 4 | University Health Network, TorontoOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT07448545 | Turkish Version of the UCLA Prostate Cancer Index | completed | — | 115 | Lokman Hekim UniversityOTHER_GOV | 1 | Mar 5, 2026 | clinicaltrials |
| NCT04288687 | A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects | completed | Phase 2 | 11 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT06472856 | Vasomotor Symptom Alleviation Through Acupuncture in Patients With Prostate Cancer(VASA Pro) | completed | N/A | 12 | University College CorkOTHER | 1 | Mar 4, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Apr 29, 2026source: clinicaltrials